Researchers conducted a study during the height of the 2014-2016 Ebola epidemic and found that a majority of participants (59.7 percent) would pay at least $1 for a vaccine.
Researchers conducted a study during the height of the 2014-2016 Ebola epidemic and found that a majority of participants (59.7 percent) would pay at least $1 for a vaccine.